Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hehlmann

Showing results (231-240 of 310) with videos related to

Pageof 31
Sort By:
Blut|February 1, 1988
Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alphaR Hehlmann, B Anger, D Messerer, et al.
Bone Marrow Transplantation|May 1, 1996
Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemiaH Heimpel, N C Allan, M Baccarani, et al.
Leukemia|November 9, 2000
Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probesS Saussele, A Weisser, M C Müller, et al.
Blood|July 15, 1993
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study GroupR Hehlmann, H Heimpel, J Hasford, et al.
British Journal of Haematology|September 30, 1998
BCR-ABL-positive progenitors in chronic myeloid leukaemia patients in complete cytogenetic remission after treatment with interferon-alphaA Reiter, S B Marley, A Hochhaus, et al.
Journal of the National Cancer Institute|June 13, 1998
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project GroupJ Hasford, M Pfirrmann, R Hehlmann, et al.
Pathology, Research and Practice|November 1, 1985
Immunopathology of AIDS (acquired immune deficiency syndrome) observations in 75 patients with pre-AIDS and AIDSG R Krueger, J K Otten, M Ortmann, et al.
Annals of Hematology|August 1, 1993
Interferon in chronic myeloid leukemia. A workshop reportM Griesshammer, R Hehlmann, A Hochhaus, et al.
Onkologie|July 7, 2001
Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II TrialG. Hartung, R. Hofheinz, D. Buchheidt, et al.
Journal of Interferon Research|August 1, 1994
Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemiaP Von Wussow, R Hehlmann, T Hochhaus, et al.
Pageof 31

Showing results (231-240 of 310) with videos related to

Sort By:
Pageof 31
Blut|February 1, 1988
Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alphaR Hehlmann, B Anger, D Messerer, et al.
Bone Marrow Transplantation|May 1, 1996
Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemiaH Heimpel, N C Allan, M Baccarani, et al.
Leukemia|November 9, 2000
Frequent polymorphism in BCR exon b2 identified in BCR-ABL positive and negative individuals using fluorescent hybridization probesS Saussele, A Weisser, M C Müller, et al.
Blood|July 15, 1993
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study GroupR Hehlmann, H Heimpel, J Hasford, et al.
British Journal of Haematology|September 30, 1998
BCR-ABL-positive progenitors in chronic myeloid leukaemia patients in complete cytogenetic remission after treatment with interferon-alphaA Reiter, S B Marley, A Hochhaus, et al.
Journal of the National Cancer Institute|June 13, 1998
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project GroupJ Hasford, M Pfirrmann, R Hehlmann, et al.
Pathology, Research and Practice|November 1, 1985
Immunopathology of AIDS (acquired immune deficiency syndrome) observations in 75 patients with pre-AIDS and AIDSG R Krueger, J K Otten, M Ortmann, et al.
Annals of Hematology|August 1, 1993
Interferon in chronic myeloid leukemia. A workshop reportM Griesshammer, R Hehlmann, A Hochhaus, et al.
Onkologie|July 7, 2001
Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II TrialG. Hartung, R. Hofheinz, D. Buchheidt, et al.
Journal of Interferon Research|August 1, 1994
Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemiaP Von Wussow, R Hehlmann, T Hochhaus, et al.
Pageof 31